NEU neuren pharmaceuticals limited

a once in a generation drug and management know it. It's not the...

  1. 207 Posts.
    lightbulb Created with Sketch. 206
    a once in a generation drug and management know it. It's not the drug you sell for a quick 200% profit. This is very possibly the Meta/Google/Apple equivalent in the pharmaceutical world

    Yet despite positive trial results, the once-in-a-generation drug's share price is $9 off its high and stagnant.

    There seems to be a lot of disconnect between the current situation and the fair weather storyline. Nothing seems to be able to move the share price in the right direction since the start of the year, not one of the presentations, conferences or results etc. Nothing at all.

    It seems so odd or is this normal?

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.02
Change
-0.260(1.82%)
Mkt cap ! $1.745B
Open High Low Value Volume
$14.44 $14.44 $14.00 $3.454M 245.0K

Buyers (Bids)

No. Vol. Price($)
10 7440 $14.00
 

Sellers (Offers)

Price($) Vol. No.
$14.11 3159 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.